Puig Brands SA (PUIG)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 19.29 |
|---|---|
| 52-week range | 13.46 – 19.63 |
| Return, 1 month / 3 months | +9.9% / +14.8% |
| Return, 1 year / 3 years | +39.4% / – |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 32.5% |
| Worst drawdown (1 year) | -18.2% |
| Average daily value traded | 9.66M EUR |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Puig Brands is a Spanish fashion and beauty company based in Barcelona. It creates and markets fragrances, cosmetics and fashion products under its own portfolio of brands, which include names such as Carolina Herrera, Nina Ricci, Paco Rabanne and Jean Paul Gaultier. Its perfumes are its core business, sold through department stores, specialist retailers and travel retail channels, and it also designs and sells clothing and accessories. The company serves customers in many countries around the world.
Puig Brands SA trades under the code PUIG on the Madrid Exchange in Spain, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Puig Brands SA (PUIG) trades on the Madrid Exchange in Spain. It last closed at EUR 19.29 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 32 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.4% and over the last three months it rose 14.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.4% | ||
| From 52-week high | -1.5% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.8% | ||
| 6-month return | 8.0% | ||
| 12-month return, skipping the last month | 26.9% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.2% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 9.66M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 21 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.2% |
|---|---|
| 1 month | +9.9% |
| 3 months | +14.8% |
| 6 months | +8.0% |
| 1 year | +39.4% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 17.96 / 16.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jun 2026 | EUR 0.4216 |
| 10 Jun 2025 | EUR 0.3768 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.